JP2021500400A5 - - Google Patents

Info

Publication number
JP2021500400A5
JP2021500400A5 JP2020542534A JP2020542534A JP2021500400A5 JP 2021500400 A5 JP2021500400 A5 JP 2021500400A5 JP 2020542534 A JP2020542534 A JP 2020542534A JP 2020542534 A JP2020542534 A JP 2020542534A JP 2021500400 A5 JP2021500400 A5 JP 2021500400A5
Authority
JP
Japan
Prior art keywords
ring portion
compound
antiviral
administering
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500400A (ja
JP7466907B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056138 external-priority patent/WO2019079339A1/en
Publication of JP2021500400A publication Critical patent/JP2021500400A/ja
Publication of JP2021500400A5 publication Critical patent/JP2021500400A5/ja
Application granted granted Critical
Publication of JP7466907B2 publication Critical patent/JP7466907B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542534A 2017-10-18 2018-10-16 広域スペクトルの抗ウイルス治療のための組成物及び方法 Active JP7466907B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762573933P 2017-10-18 2017-10-18
US62/573,933 2017-10-18
PCT/US2018/056138 WO2019079339A1 (en) 2017-10-18 2018-10-16 COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTIVIRAL THERAPY

Publications (3)

Publication Number Publication Date
JP2021500400A JP2021500400A (ja) 2021-01-07
JP2021500400A5 true JP2021500400A5 (cg-RX-API-DMAC7.html) 2023-02-03
JP7466907B2 JP7466907B2 (ja) 2024-04-15

Family

ID=66173467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542534A Active JP7466907B2 (ja) 2017-10-18 2018-10-16 広域スペクトルの抗ウイルス治療のための組成物及び方法

Country Status (6)

Country Link
US (1) US12213955B2 (cg-RX-API-DMAC7.html)
EP (1) EP3697404B1 (cg-RX-API-DMAC7.html)
JP (1) JP7466907B2 (cg-RX-API-DMAC7.html)
CN (1) CN111886008B (cg-RX-API-DMAC7.html)
TW (1) TWI860281B (cg-RX-API-DMAC7.html)
WO (1) WO2019079339A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018089306A1 (en) 2016-11-10 2018-05-17 Oyagen, Inc. Methods of treating and inhibiting ebola virus infection
CN112789925B (zh) * 2019-06-27 2023-06-02 Oppo广东移动通信有限公司 用于指示空间关系信息的方法和设备
WO2021158248A1 (en) 2020-02-04 2021-08-12 Oyagen, Inc. Method for treating coronavirus infections
MX2022011111A (es) * 2020-03-08 2023-03-02 Humanigen Inc Métodos para tratar infección de coronavirus y lesión pulmonar inducida por inflamación resultante.
US11628165B1 (en) * 2020-03-25 2023-04-18 Helen Feng Method of boosting immune system against viral infection
ES2862462B2 (es) * 2020-04-06 2023-04-27 Servicio Andaluz De Salud Compuestos para la profilaxis y/o el tratamiento del sindrome de dificultad respiratoria aguda
WO2021211738A1 (en) * 2020-04-15 2021-10-21 Sanford Burnham Prebys Medical Discovery Institute Methods and compositions for antiviral treatment
WO2021226479A1 (en) * 2020-05-07 2021-11-11 The Regents Of The University Of California Inhaled statins for treatment of viral respiratory diseases
EP4153157A4 (en) * 2020-05-22 2024-06-05 Riveros, Carlos Alberto System, method and use of a certain medication for reducing viral replication in the airways mucosae
EP4186505A4 (en) * 2020-06-11 2024-06-19 Yang Sheng Tang Company, Ltd. USE OF PALOVAROTEN TO TREAT HBV VIRUS
WO2022006446A1 (en) * 2020-07-02 2022-01-06 The Uab Research Foundation Compositions and methods of treating conditions
CN112390731B (zh) * 2020-11-16 2022-11-25 成都大学 一种具有多靶点的维甲酸类衍生物及其制备方法与应用
US11998562B2 (en) 2021-01-25 2024-06-04 University Of South Florida Ophthalmological formulations for the prevention of a coronavirus infection
US20240115607A1 (en) 2021-01-26 2024-04-11 Cytocares (Shanghai) Inc. Chimeric antigen receptor (car) constructs and nk cells expressing car constructs
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery
CN116891497B (zh) * 2022-04-02 2025-12-16 上海旭成医药科技有限公司 视黄酸受体激动剂、其制备方法、中间体、药物组合物和应用
EP4516299A4 (en) * 2022-04-28 2025-12-17 National Univ Corporation Tokai National Higher Education And Research System Pharmaceutical composition for the treatment of heart failure with diastolic dysfunction
CN119454680B (zh) * 2024-12-06 2025-06-17 华南农业大学 贝沙罗汀在制备抗prrsv或治疗猪蓝耳病的药物中的应用
CN121177272B (zh) * 2025-11-10 2026-06-19 北京市农林科学院 化合物am580在预防或治疗塞内卡病毒病中的用途
CN121943910A (zh) * 2026-03-23 2026-05-01 华南农业大学 一种RARα特异性拮抗剂在防治猪繁殖与呼吸综合征中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341717B2 (en) * 2001-04-13 2008-03-11 Gpc Biotech Ag Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor
WO2004050101A2 (en) * 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
WO2005120479A1 (en) 2004-06-09 2005-12-22 Gpc Biotech Ag Use of selenium or a selenium salt and a retinoid acid or a retinoid in the treatment of viral hepatitis c
EP1886685A1 (en) 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
MX2009007667A (es) * 2007-01-18 2011-12-08 Evolva Sa Profarmacos de 1,3-dioxanos sustituidos y sus usos.
CN104662036B (zh) * 2012-04-25 2018-11-09 华辉安健(北京)生物科技有限公司 乙肝肝炎病毒功能性受体的组成以及相关应用
WO2014079709A1 (en) 2012-11-23 2014-05-30 Ab Science Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections
MX2016010699A (es) * 2014-02-18 2017-10-11 Children's Hospital Los Angeles Composiciones y metodos para tratar neutropenia.
EP3563683B1 (en) 2014-03-10 2021-03-31 Cornell University Combination therapy for head and neck cancer
WO2018054891A1 (en) 2016-09-20 2018-03-29 Ruprecht-Karls-Universität Compounds and combinations thereof for preventing and/or treating hbv and/or hdv infections

Similar Documents

Publication Publication Date Title
JP2017523796A5 (cg-RX-API-DMAC7.html)
JP2019515674A5 (cg-RX-API-DMAC7.html)
JP2017048194A5 (cg-RX-API-DMAC7.html)
JP2016537341A5 (cg-RX-API-DMAC7.html)
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
EA201600476A1 (ru) Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение
JP2017524348A5 (cg-RX-API-DMAC7.html)
JP2017532302A5 (cg-RX-API-DMAC7.html)
CO2017010162A2 (es) Nucleótidos de purina ß-d-2'-desoxi-2'-α-fluoro-2'-ß-c-sustituidos-2-modificados-n6-sustituidos para el tratamiento del virus de la hepatitis c
JP2018520997A5 (cg-RX-API-DMAC7.html)
JP2016074736A5 (cg-RX-API-DMAC7.html)
JO3489B1 (ar) مركبات تراي أزولوبيريميدين واستخداماتها
JP2013005803A5 (cg-RX-API-DMAC7.html)
JP2015525207A5 (cg-RX-API-DMAC7.html)
EA202190602A3 (ru) 2'-замещенные-n6-замещенные пуриновые нуклеотиды для лечения вызванных рнк-вирусом заболеваний
JP2013032389A5 (cg-RX-API-DMAC7.html)
JP2016537338A5 (cg-RX-API-DMAC7.html)
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2019516789A5 (cg-RX-API-DMAC7.html)
JP2017529355A5 (cg-RX-API-DMAC7.html)
MX2011002309A (es) Anticuerpos de aves especificos para virus de influenza y metodos tecnologicamente sencillos de su fabricacion y uso.
CN111868057A (zh) 一种二氢嘧啶类化合物的固体形式及其制备方法和用途
EP4355880A4 (en) TEMPERATURE-SENSITIVE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES
JP2021502362A5 (cg-RX-API-DMAC7.html)
JP2014136801A5 (cg-RX-API-DMAC7.html)